Danaher Corp

Danaher CEO Rainer Blair to speak at Jefferies Global Healthcare Conference, highlighting Danaher’s growth strategy and influence on AI‑driven health tech.

Danaher Corp. stock hits $211.17, faces a “hold” downgrade amid CEO talks at the Jefferies Healthcare Conference—long‑term gains still strong.

Danaher Corp, a leading player in the healthcare equipment and supplies sector, has shown resilience in the face of challenges, with a strong market presence and a clear vision for the future.

Danaher Corp reports a decline in profit but beats earnings expectations, while also announcing a leadership transition and raising its full-year guidance, positioning the company for long-term growth.

Danaher Corp’s stock has declined 25% in the past year, but billionaire Lei Zhang’s endorsement suggests potential for long-term growth, leaving investors to weigh the risks and opportunities.